Literature DB >> 18778770

In-vitro tomography and non-destructive imaging at depth of pharmaceutical solid dosage forms.

J Axel Zeitler1, Lynn F Gladden.   

Abstract

Tomographic imaging techniques offer new prospects for a better understanding of the quality, performance and release mechanisms of pharmaceutical solid dosage forms. It is only over the last fifteen years that tomography has been applied for the in-vitro characterisation of dosage forms. This review aims to introduce the concept of tomography in a pharmaceutical context, and describes the current state-of-the-art of the four most promising techniques: X-ray computed microtomography, magnetic resonance imaging, terahertz imaging and optical coherence tomography. The basic working principles of the techniques are introduced and the current pharmaceutical applications of the technologies are discussed, together with a comparison of their specific strengths and weaknesses. Possible future developments in these fields are also discussed.

Mesh:

Substances:

Year:  2008        PMID: 18778770     DOI: 10.1016/j.ejpb.2008.08.012

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  16 in total

1.  Real-time UV imaging of nicotine release from transdermal patch.

Authors:  Jesper Østergaard; Emil Meng-Lund; Susan Weng Larsen; Claus Larsen; Karsten Petersson; James Lenke; Henrik Jensen
Journal:  Pharm Res       Date:  2010-09-02       Impact factor: 4.200

2.  Novel application of MRI technique combined with flow-through cell dissolution apparatus as supportive discriminatory test for evaluation of controlled release formulations.

Authors:  Przemyslaw P Dorozyński; Piotr Kulinowski; Aleksander Mendyk; Anna Młynarczyk; Renata Jachowicz
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

3.  Tunable compact narrow band THz sources for frequency domain THz anisotropic spectroscopy.

Authors:  D K George; T J LaFAve; A G Markelz; Ian McNee; Peter Schunemann
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2019-05-13

4.  Characterization of Continuous and Pulsed Emission modes of a Hybrid Micro Focus X-ray Source for Medical Imaging Applications.

Authors:  Muhammad U Ghani; Molly D Wong; Liqiang Ren; Di Wu; Bin Zheng; John X Rong; Xizeng Wu; Hong Liu
Journal:  Nucl Instrum Methods Phys Res A       Date:  2017-02-16       Impact factor: 1.455

5.  Wavelength shifting of intra-cavity photons: Adiabatic wavelength tuning in rapidly wavelength-swept lasers.

Authors:  Christian Jirauschek; Robert Huber
Journal:  Biomed Opt Express       Date:  2015-06-12       Impact factor: 3.732

6.  Evaluation of coating properties of enteric-coated tablets using terahertz pulsed imaging.

Authors:  Masahiro Niwa; Yasuhiro Hiraishi; Katsuhide Terada
Journal:  Pharm Res       Date:  2014-02-27       Impact factor: 4.200

7.  Anisotropic porous structure of pharmaceutical compacts evaluated by PGSTE-NMR in relation to mechanical property anisotropy.

Authors:  Patrice Porion; Virginie Busignies; Vincent Mazel; Bernard Leclerc; Pierre Evesque; Pierre Tchoreloff
Journal:  Pharm Res       Date:  2010-08-10       Impact factor: 4.200

8.  Spherical Agglomerates of Lactose Reduce Segregation in Powder Blends and Improve Uniformity of Tablet Content at High Drug Loads.

Authors:  Dejan Lamešić; Blaž Grilc; Robert Roškar; Selina Kolokytha; Jürgen Hofmann; Andreas Malekos; Rolf Kaufmann; Odon Planinšek
Journal:  AAPS PharmSciTech       Date:  2021-12-10       Impact factor: 3.246

9.  Release behaviour of single pellets and internal fine 3D structural features co-define the in vitro drug release profile.

Authors:  Shuo Yang; Xianzhen Yin; Caifen Wang; Haiyan Li; You He; Tiqiao Xiao; Lixin Sun; Jiasheng Li; Peter York; Jun He; Jiwen Zhang
Journal:  AAPS J       Date:  2014-05-30       Impact factor: 4.009

10.  Magnetic resonance imaging and image analysis for assessment of HPMC matrix tablets structural evolution in USP Apparatus 4.

Authors:  Piotr Kulinowski; Przemysław Dorożyński; Anna Młynarczyk; Władysław P Węglarz
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.